Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis.
about
Plasma total antioxidant capacity and peroxidation biomarkers in psoriasisRelation of serum total antioxidant status with metabolic risk factors in Korean adults.Redox imbalance in T cell-mediated skin diseases.Psoriasis and comorbidities: links and risks.Accumulation of oxidized low-density lipoprotein in psoriatic skin and changes of plasma lipid levels in psoriatic patients.Role of C-reactive protein as a marker of disease severity and cardiovascular risk in patients with psoriasis.Risk and predictors of cardiovascular disease in psoriasis: a population-based study.Topical apigenin improves epidermal permeability barrier homoeostasis in normal murine skin by divergent mechanisms.Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.Psoriasis comorbidities.A clinical and epidemiological study of psoriasis and its association with various biochemical parameters in newly diagnosed cases.Lipid disturbances in psoriasis: an update.Psoriasis and physical activity: a review.Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis.Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis.Role of oxidative stress in various stages of psoriasis.Association of lipid peroxidation and antioxidant status with metabolic syndrome in Iranian healthy elderly womenThe serum levels of malondialdehyde, vitamin e and erythrocyte catalase activity in psoriasis patients.Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity.Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.Impact of depressive symptoms on oxidative stress in patients with psoriasis.Effects of zinc on interleukins and antioxidant enzyme values in psoriasis-induced mice.Erythrocyte damage in mild and severe psoriasis.Methylentetrahydrofolatereductase (rs1801133) polymorphism and psoriasis: contribution to oxidative stress, lipid peroxidation and correlation with vascular adhesion protein 1, preliminary report.Relationship between smoking-induced oxidative stress and the clinical severity of psoriasis.Pro-oxidant status and Nrf2 levels in psoriasis vulgaris skin tissues and dimethyl fumarate-treated HaCaT cells.Sister chromatid exchange analysis in patients with psoriasis.The lipid profile in psoriasis: a controlled study.Antioxidants in dermatology.Impact of methotrexate on oxidative stress and apoptosis markers in psoriatic patients.Identification of unique proteomic signatures in allergic and non-allergic skin disease.Prevalence of metabolic syndrome in children with moderate to severe psoriasis treated with TNF inhibitors in comparison to conventional agents.Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis.Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment.Assessment of an imiquimod-induced psoriatic mouse model in relation to oxidative stress.Serum paraoxonase-1 activities and oxidative status in patients with plaque-type psoriasis with/without metabolic syndrome.Serum lipid level in Iranian patients with psoriasis.Psoriasis & cardiovascular morbidity: The missing links?Effect of antipsoriatic therapy on oxidative stress index and sialic acid levels in patients with psoriasis
P2860
Q26744708-37183582-879A-4000-8F7B-B756AFCD478AQ33767615-45D3BFB1-072E-4CA2-970E-90E0C1CBDC97Q34089304-A82D12F5-009A-4739-A04A-15E762646E79Q34418506-49198C7A-808E-42FA-B622-357C39B942D0Q35649236-4E8AC1B1-83DE-4750-8DB2-3FF8BC96AEB2Q36124545-145482B6-25BF-4C32-B9D6-7E6E4C7D0FC3Q36515160-354F0731-BDB4-4B67-BB12-68DA8E6484B2Q36765050-D530F1B2-AA68-4CF2-AD8B-6B4B1C905E99Q36879686-908A28E6-A260-4FF1-BA07-228595ABEB60Q37084274-8FD62C27-C160-442A-B0F7-8674BFCA9144Q37573136-51A77E91-697F-4FCA-94A2-A04B7E370C5CQ37779736-46864192-5076-4B71-B4AA-784DD251EDD0Q37990043-EE7577AD-355A-4195-8BFD-BFD668F6DF76Q38095512-555B4BD9-FD6F-4DF9-908D-63D47C48CC83Q38749538-C3BB7823-50F3-48BC-914C-B52157EA7818Q41380576-DC21FBBC-21FE-45BA-85C7-65336674FF47Q41530344-E28B7987-034A-4F77-9BEC-764B1E2F23CBQ43100840-09AC04DF-8060-472E-898F-9C4F2C8D3409Q43472253-84B2495C-9E0D-49AD-AB12-016F5BF4984EQ43545547-50CF3E88-5D57-4BED-8554-C88DEC9DE529Q44404125-DDBF33B3-C40B-49A9-A026-C1E531EE520FQ44443011-91AA99B3-C5E2-42C6-9A4C-F89830BAA0B2Q44783499-B9A5E1DE-A170-4D83-9395-EDD489348682Q44906304-7860079E-24CE-4186-BC23-CEEDCC17E6AFQ46170910-7D838ADC-0AA4-48D5-A3BA-554D4A68CE23Q46305804-B310D583-AD09-40E2-90B1-4FA6E0BE6BC0Q46821653-47B1960C-6E9A-4B8E-8968-4C7454D509D4Q46933619-CD8443EF-5824-4665-8A09-C1821264E73FQ47139129-8A2CEEA1-2D53-4E70-8C40-B8BBAFFD3925Q47770582-5E909EFC-0E01-483E-B3AB-64C30209C239Q48132224-E82A4021-0096-4A11-A5A3-871F2B259166Q48244028-165CDE73-443E-46E2-8026-F6F97FF59E20Q49249983-05D78AA0-96E3-4C0C-9C41-C64CF5457447Q51045110-DC3AFF19-F860-441C-B167-39240DE353EFQ51320292-C44D067E-387F-4FFE-B61F-A61C5789E379Q51370354-0E3E13B1-BC22-4C0B-8E22-4CCCAFE7E9CBQ51469568-B2C74857-1CB0-454F-B05F-0026B4C38AFDQ55365402-F3C796C5-21C6-4FEC-BD9F-AE005A87B244Q58623301-2EB8AB42-CA37-4CEA-8B9D-29C92548FB3B
P2860
Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Evaluation of the atherogenic ...... em in patients with psoriasis.
@en
Evaluation of the atherogenic ...... em in patients with psoriasis.
@nl
type
label
Evaluation of the atherogenic ...... em in patients with psoriasis.
@en
Evaluation of the atherogenic ...... em in patients with psoriasis.
@nl
prefLabel
Evaluation of the atherogenic ...... em in patients with psoriasis.
@en
Evaluation of the atherogenic ...... em in patients with psoriasis.
@nl
P2093
P1433
P1476
Evaluation of the atherogenic ...... em in patients with psoriasis.
@en
P2093
Birgül Vanizor Kural
Gülseren Cimşit
Mustafa Calapoglu
Yunus Emre Yandi
P356
10.1016/S0009-8981(02)00373-X
P577
2003-02-01T00:00:00Z